|
ossification
|
GO:0001503 |
216 |
0.993
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.992
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.869
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.850
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.829
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.812
|
|
|
divalent inorganic anion homeostasis
|
GO:0072505 |
5 |
0.805
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.775
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.767
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.759
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.759
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.724
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.711
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.710
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.688
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.674
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.663
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.662
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.630
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.599
|
|
|
aldosterone biosynthetic process
|
GO:0032342 |
1 |
0.585
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.581
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.581
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.571
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.570
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.568
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.563
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.558
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.542
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.540
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.537
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.536
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.533
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.530
|
|
|
anion transport
|
GO:0006820 |
177 |
0.526
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.515
|
|
|
cellular divalent inorganic anion homeostasis
|
GO:0072501 |
3 |
0.513
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.511
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.506
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.499
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.477
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.472
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.471
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.463
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.453
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.448
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.426
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.424
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.413
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.408
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.405
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.397
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.391
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.386
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.378
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.375
|
|
|
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072040 |
4 |
0.370
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.368
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.366
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.357
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.353
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.353
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.346
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.343
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.343
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.341
|
|
|
kidney development
|
GO:0001822 |
213 |
0.336
|
|
|
phosphate ion transmembrane transport
|
GO:0035435 |
2 |
0.336
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.333
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.330
|
|
|
negative regulation of steroid metabolic process
|
GO:0045939 |
8 |
0.327
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.326
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.322
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.311
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.310
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.306
|
|
|
mesenchymal cell differentiation involved in lung development
|
GO:0060915 |
2 |
0.294
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.290
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.289
|
|
|
neuronal stem cell division
|
GO:0036445 |
10 |
0.288
|
|
|
phosphate ion homeostasis
|
GO:0055062 |
5 |
0.286
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.284
|
|
|
appendage development
|
GO:0048736 |
166 |
0.283
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.280
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.270
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.264
|
|
|
aorta morphogenesis
|
GO:0035909 |
22 |
0.264
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.261
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.260
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.259
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.257
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.252
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.249
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.248
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.247
|
Mouse |
|
muscle tissue development
|
GO:0060537 |
308 |
0.245
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.244
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.244
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.244
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.237
|
|
|
brain derived neurotrophic factor receptor signaling pathway
|
GO:0031547 |
3 |
0.235
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.235
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.234
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.233
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.231
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.230
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.230
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.229
|
|
|
bone development
|
GO:0060348 |
120 |
0.228
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.228
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.223
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.222
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.221
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.221
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.217
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.217
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.216
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.214
|
|
|
axial mesodermal cell fate commitment
|
GO:0048322 |
1 |
0.214
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.213
|
|
|
cellular trivalent inorganic anion homeostasis
|
GO:0072502 |
2 |
0.213
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.209
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.209
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.208
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.208
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.206
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.205
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.204
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.203
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.202
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.201
|
|
|
enamel mineralization
|
GO:0070166 |
7 |
0.200
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.199
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.197
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.190
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.190
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.190
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.189
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.188
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.187
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.186
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.185
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.181
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.178
|
|
|
renal system development
|
GO:0072001 |
225 |
0.177
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.174
|
|
|
regulation of positive chemotaxis
|
GO:0050926 |
7 |
0.173
|
|
|
neuroblast division
|
GO:0055057 |
10 |
0.172
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.171
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.171
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.170
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.170
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.170
|
|
|
face development
|
GO:0060324 |
38 |
0.168
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.167
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.166
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.166
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.164
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.162
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.162
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.162
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.160
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.160
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.160
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.159
|
|
|
pallium development
|
GO:0021543 |
120 |
0.157
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.157
|
|
|
regulation of aldosterone metabolic process
|
GO:0032344 |
1 |
0.156
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.155
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.155
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.155
|
|
|
placenta development
|
GO:0001890 |
140 |
0.154
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.153
|
|
|
forebrain ventricular zone progenitor cell division
|
GO:0021869 |
6 |
0.152
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.152
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.151
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.151
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.150
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.149
|
|
|
ventricular zone neuroblast division
|
GO:0021847 |
3 |
0.148
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.147
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.146
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.146
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.145
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.144
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.144
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.144
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.143
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.141
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.141
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.140
|
|
|
prenylation
|
GO:0097354 |
3 |
0.139
|
|
|
extracellular matrix cell signaling
|
GO:0035426 |
5 |
0.139
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.139
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.139
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.139
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.139
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.139
|
|
|
embryonic skeletal joint development
|
GO:0072498 |
13 |
0.137
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.137
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.136
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.136
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.135
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.133
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.133
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.133
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.131
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.130
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.130
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.130
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.129
|
|
|
metanephric mesenchymal cell proliferation involved in metanephros development
|
GO:0072136 |
2 |
0.129
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.129
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.129
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.129
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.128
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.128
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.128
|
|
|
regulation of protein geranylgeranylation
|
GO:2000539 |
2 |
0.128
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.127
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.127
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
17 |
0.127
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.126
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.126
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.126
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.125
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.124
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.123
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.122
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.121
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.121
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.121
|
|
|
morphogenesis of an epithelial bud
|
GO:0060572 |
18 |
0.120
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.120
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.119
|
|
|
mammary gland bud formation
|
GO:0060615 |
2 |
0.119
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.118
|
|
|
cation transport
|
GO:0006812 |
399 |
0.118
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.118
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.118
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.118
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.117
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.117
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.117
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.115
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.115
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.114
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.113
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.111
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.111
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.110
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.110
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.110
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.110
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.109
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.109
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.108
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.107
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.107
|
|
|
response to vitamin d
|
GO:0033280 |
3 |
0.107
|
|
|
renal sodium ion transport
|
GO:0003096 |
2 |
0.106
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.106
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.106
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.105
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.104
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.103
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.103
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.101
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.101
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.101
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.100
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
29 |
0.100
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.100
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.099
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.098
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.098
|
|
|
positive regulation of tendon cell differentiation
|
GO:2001051 |
1 |
0.098
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.098
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.098
|
|
|
trachea formation
|
GO:0060440 |
3 |
0.097
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.096
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.096
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.095
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.095
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.095
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.095
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
20 |
0.095
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.095
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.094
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.094
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.094
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.094
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.094
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.094
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.093
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.093
|
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.092
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.092
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.092
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.092
|
|
|
gland development
|
GO:0048732 |
330 |
0.091
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.091
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.091
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.091
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.090
|
|
|
c21 steroid hormone metabolic process
|
GO:0008207 |
7 |
0.090
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.090
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.089
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.089
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.088
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.088
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.088
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.087
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.087
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.087
|
|
|
protein geranylgeranylation
|
GO:0018344 |
3 |
0.086
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.086
|
|
|
wound healing
|
GO:0042060 |
157 |
0.086
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.086
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.086
|
|
|
roof plate formation
|
GO:0021509 |
1 |
0.085
|
|
|
limb development
|
GO:0060173 |
166 |
0.085
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.085
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.085
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.085
|
|
|
regulation of rac gtpase activity
|
GO:0032314 |
13 |
0.085
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.084
|
|
|
monovalent inorganic anion homeostasis
|
GO:0055083 |
6 |
0.084
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.084
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.084
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.084
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.083
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.083
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.083
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.083
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.083
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.082
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.082
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.082
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.082
|
|
|
positive regulation of bone mineralization
|
GO:0030501 |
12 |
0.082
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.082
|
|
|
specification of organ position
|
GO:0010159 |
3 |
0.082
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.082
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.082
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.081
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.080
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.080
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.080
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.080
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.080
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.080
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.078
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.078
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.078
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.077
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.076
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.076
|
|
|
cell division
|
GO:0051301 |
120 |
0.075
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.075
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.075
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.075
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.075
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.074
|
|
|
camp mediated signaling
|
GO:0019933 |
15 |
0.074
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.073
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.073
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.073
|
|
|
organ growth
|
GO:0035265 |
117 |
0.073
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.073
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.073
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
26 |
0.073
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.072
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.072
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.072
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.072
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.072
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.072
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.071
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.071
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.071
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.071
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.071
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.071
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.070
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.070
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.070
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.070
|
|
|
cellular response to vitamin
|
GO:0071295 |
2 |
0.070
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.070
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.070
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.070
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.070
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.070
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.069
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.069
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.068
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.068
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.068
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.068
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.068
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.067
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.067
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.067
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.067
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.067
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.067
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.067
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.066
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.066
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.066
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.066
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.066
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.065
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.065
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.065
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.065
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.065
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.065
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.064
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.064
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.064
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.064
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.064
|
Mouse |
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.063
|
|
|
positive chemotaxis
|
GO:0050918 |
18 |
0.063
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.063
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.063
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.063
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.063
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.062
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.062
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.062
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.062
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.062
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.061
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.061
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.061
|
|
|
wnt signaling pathway involved in somitogenesis
|
GO:0090244 |
4 |
0.061
|
|
|
positive regulation of high voltage gated calcium channel activity
|
GO:1901843 |
1 |
0.061
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.061
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.061
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.060
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.060
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.060
|
|
|
regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010640 |
9 |
0.059
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.059
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.059
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.059
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.059
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.058
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.058
|
|
|
cognition
|
GO:0050890 |
149 |
0.057
|
|
|
negative regulation of muscle hypertrophy
|
GO:0014741 |
9 |
0.057
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.057
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.057
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.056
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.056
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.056
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.055
|
|
|
branch elongation involved in salivary gland morphogenesis
|
GO:0060667 |
2 |
0.055
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.055
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.055
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.055
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.055
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.054
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.054
|
|
|
regulation of mesenchymal cell apoptotic process
|
GO:2001053 |
14 |
0.054
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.054
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.054
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.054
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.053
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.053
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.053
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.053
|
|
|
embryonic skeletal joint morphogenesis
|
GO:0060272 |
11 |
0.053
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.053
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.053
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.053
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.052
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.052
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.052
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.052
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.052
|
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.052
|
|